Suppr超能文献

生长因子诱导的固醇调节元件结合蛋白磷酸化抑制了类泛素化修饰,从而刺激其靶基因的表达、低密度脂蛋白摄取及脂质合成。

Growth factor-induced phosphorylation of sterol regulatory element-binding proteins inhibits sumoylation, thereby stimulating the expression of their target genes, low density lipoprotein uptake, and lipid synthesis.

作者信息

Arito Mitsumi, Horiba Taro, Hachimura Satoshi, Inoue Jun, Sato Ryuichiro

机构信息

Department of Applied Biological Chemistry, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan.

出版信息

J Biol Chem. 2008 May 30;283(22):15224-31. doi: 10.1074/jbc.M800910200. Epub 2008 Apr 9.

Abstract

The destiny and activity of sterol regulatory element-binding proteins (SREBPs) in the nucleus are regulated by modification with ubiquitin, small ubiquitin-like modifier (SUMO), or phosphorus. ERK-dependent phosphorylation causes an increase in their transcriptional activity, whereas SUMO modification halts it. We hypothesized a causal linkage between phosphorylation and sumoylation because their sites are very closely located in SREBP-1 and -2 molecules. When Ser(455), a phosphorylation site in SREBP-2, was substituted with Ala, this SREBP-2 mutant was more efficiently modified by SUMO-1. On the other hand, substitution of Asp inhibited SUMO conjugation, mimicking phosphoserine. When cells were cultured with insulin-like growth factor-1, sumoylation of SREBP-2 was decreased with an increase in its phosphorylation, but SREBP-2(S455A) was continuously sumoylated. An ERK cascade inhibitor, U0126, inversely augmented SUMO modification of SREBP-2. Insulin-like growth factor-1 treatment stimulated the expression of SREBP target genes such as the low density lipoprotein (LDL) receptor, squalene synthase, and hydroxymethylglutaryl-CoA synthase genes. These results indicate that growth factor-induced phosphorylation of SREBP-2 inhibits sumoylation, thereby facilitating SREBP transcriptional activity. Glutathione S-transferase pulldown assays revealed that wild-type SREBP-2, but not a mutant lacking Lys(464), interacts with HDAC3 preferentially among the histone deacetylase family members. HDAC3 small interfering RNA induced gene expression of the LDL receptor and thereby augmented fluorescently labeled LDL uptake in HepG2 cells. In summary, growth factors inhibit sumoylation of SREBPs through their phosphorylation, thus avoiding the recruitment of an HDAC3 corepressor complex and stimulating the lipid uptake and synthesis required for cell growth.

摘要

固醇调节元件结合蛋白(SREBPs)在细胞核中的命运和活性受泛素、小泛素样修饰物(SUMO)或磷酸化修饰的调控。细胞外调节蛋白激酶(ERK)依赖性磷酸化导致其转录活性增加,而SUMO修饰则使其转录活性停止。我们推测磷酸化和SUMO化之间存在因果联系,因为它们的位点在SREBP-1和-2分子中位置非常接近。当SREBP-2中的磷酸化位点Ser(455)被丙氨酸替代时,这种SREBP-2突变体被SUMO-1更有效地修饰。另一方面,天冬氨酸替代抑制了SUMO缀合,模拟了磷酸丝氨酸。当细胞用胰岛素样生长因子-1培养时,SREBP-2的SUMO化随着其磷酸化增加而减少,但SREBP-2(S455A)持续被SUMO化。ERK级联抑制剂U0126反向增强了SREBP-2的SUMO修饰。胰岛素样生长因子-1处理刺激了SREBP靶基因如低密度脂蛋白(LDL)受体、角鲨烯合酶和羟甲基戊二酰辅酶A合酶基因的表达。这些结果表明,生长因子诱导的SREBP-2磷酸化抑制了SUMO化,从而促进了SREBP转录活性。谷胱甘肽S-转移酶下拉试验表明,野生型SREBP-2而非缺乏Lys(464)的突变体在组蛋白去乙酰化酶家族成员中优先与HDAC3相互作用。HDAC3小干扰RNA诱导LDL受体的基因表达,从而增强了HepG2细胞中荧光标记的LDL摄取。总之,生长因子通过磷酸化抑制SREBPs的SUMO化,从而避免募集HDAC3共抑制复合物并刺激细胞生长所需的脂质摄取和合成。

相似文献

5
The physiological role of sterol regulatory element-binding protein-2 in cultured human cells.
Biochim Biophys Acta. 1999 Jan 4;1436(3):307-18. doi: 10.1016/s0005-2760(98)00119-2.
8
Identification of miR-185 as a regulator of de novo cholesterol biosynthesis and low density lipoprotein uptake.
J Lipid Res. 2014 Feb;55(2):226-38. doi: 10.1194/jlr.M041335. Epub 2013 Dec 2.
9
Low-temperature effect on the sterol-dependent processing of SREBPs and transcription of related genes in HepG2 cells.
J Lipid Res. 2003 Aug;44(8):1581-90. doi: 10.1194/jlr.M300105-JLR200. Epub 2003 May 16.

引用本文的文献

1
Unlocking the lipid code: SREBPs as key drivers in gastrointestinal tumour metabolism.
Lipids Health Dis. 2025 May 24;24(1):190. doi: 10.1186/s12944-025-02612-8.
2
RNAi-based ALOX15B silencing augments keratinocyte inflammation in vitro via EGFR/STAT1/JAK1 signalling.
Cell Death Dis. 2025 Jan 22;16(1):39. doi: 10.1038/s41419-025-07357-x.
3
Roles of posttranslational modifications in lipid metabolism and cancer progression.
Biomark Res. 2024 Nov 18;12(1):141. doi: 10.1186/s40364-024-00681-y.
4
TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer.
J Exp Clin Cancer Res. 2024 Aug 7;43(1):219. doi: 10.1186/s13046-024-03142-4.
5
The emerging roles of SUMOylation in the tumor microenvironment and therapeutic implications.
Exp Hematol Oncol. 2023 Jul 6;12(1):58. doi: 10.1186/s40164-023-00420-3.
7
DAXX drives de novo lipogenesis and contributes to tumorigenesis.
Nat Commun. 2023 Apr 12;14(1):1927. doi: 10.1038/s41467-023-37501-0.
8
Intracellular Cholesterol Synthesis and Transport.
Front Cell Dev Biol. 2022 Mar 21;10:819281. doi: 10.3389/fcell.2022.819281. eCollection 2022.
9
Prostate Cancer-Focus on Cholesterol.
Cancers (Basel). 2021 Sep 19;13(18):4696. doi: 10.3390/cancers13184696.
10
Not So Slim Anymore-Evidence for the Role of SUMO in the Regulation of Lipid Metabolism.
Biomolecules. 2020 Aug 6;10(8):1154. doi: 10.3390/biom10081154.

本文引用的文献

1
Elevated level of SUMOylated IRF-1 in tumor cells interferes with IRF-1-mediated apoptosis.
Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17028-33. doi: 10.1073/pnas.0609852104. Epub 2007 Oct 17.
2
SUMOylation regulates kainate-receptor-mediated synaptic transmission.
Nature. 2007 May 17;447(7142):321-5. doi: 10.1038/nature05736. Epub 2007 May 7.
5
Protein sensors for membrane sterols.
Cell. 2006 Jan 13;124(1):35-46. doi: 10.1016/j.cell.2005.12.022.
6
PDSM, a motif for phosphorylation-dependent SUMO modification.
Proc Natl Acad Sci U S A. 2006 Jan 3;103(1):45-50. doi: 10.1073/pnas.0503698102. Epub 2005 Dec 21.
8
Hyperphosphorylation regulates the activity of SREBP1 during mitosis.
Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11681-6. doi: 10.1073/pnas.0501494102. Epub 2005 Aug 4.
10
Identification of a SUMO-binding motif that recognizes SUMO-modified proteins.
Proc Natl Acad Sci U S A. 2004 Oct 5;101(40):14373-8. doi: 10.1073/pnas.0403498101. Epub 2004 Sep 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验